# Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution

> **NCT04678076** · PHASE1 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ketoprofen Lysine
- **DRUG:** Ketoprofen Oral Product

## Key facts

- **NCT ID:** NCT04678076
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-23
- **Primary completion:** 2018-08-05
- **Final completion:** 2018-08-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04678076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04678076, "Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04678076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*